BNH
VC Fund
BNH is a VC fund focused on Health Care and Biotechnology. BNH Investment Group is an real estate investment Management focused on providing investment solutions for SFH in the US market.
- Total investments:
- 6
- Last investment:
- Lead investor:
- 17%
Last updated:
For AI agents: llms.txt
Industries BNH invests in
Stages BNH invests in
Countries BNH invests in
Investment Focus
Industry
- Health Care 3 (50%)
- Biotechnology 3 (50%)
- Medical 2 (33%)
- Therapeutics 2 (33%)
- Health Diagnostics 2 (33%)
Stage
- Series A 2 (33%)
- Series B 2 (33%)
- Venture - Series Unknown 2 (33%)
Country
- South Korea 3 (50%)
- China 1 (17%)
- United States 1 (17%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Imagoworks Inc. offers a Web-based Dental CAD solution using AI, streamlining the digital workflow for dental professionals. Together with world-class technology, we are setting new standards for digital dentistry in the global market. Our mission is to <Making the future of digital medicine for everyone>.While we have accumulatedtechnological expertise in the medical field for over 10 years, specializing in AI-based automation, 3D geometric modeling and mesh processing, and software as a service (SaaS), we now turn our focus to commercializing our innovative technologies and transforming the field of digital dentistry. By cooperating with and licensing to leading global dental companies, we are seeing great success as we find ourselves in the industry spotlight.Imagoworks currently offers Dentbird Crown which automatically generates optimal crown designs with a single click and without any software installation required. As we continue to expand our services, Imagoworks aims to be recognized as a chairside design solution for dentists worldwide. | $7M / Series B / Nov 03, 2022 | ||
| Speclipse is a transformative, patented technology for real-time, non-invasive, in-vivo cancer diagnosis utilizing laser spectroscopy and machining learning algorithms. | $7.7M / Venture - Series Unknown / Aug 19, 2021 | ||
| Aardvark Therapeutics specializes in small molecule therapeutics for obesity and rare genetic metabolic disorders. Aardvark Therapeutics was founded by Tien Lee in 2017. | $29M / Series B / Aug 05, 2021 | ||
| Cytovant is a biopharmaceutical company focused on developing novel and innovative cellular therapeutics. The company focuses on developing modified T-cell receptor therapeutics and dendritic cell vaccines that target tumor antigens to improve tumor cells therapy and treatment. | $23.5M / Venture - Series Unknown / Apr 03, 2020 | ||
| Aardvark Therapeutics specializes in small molecule therapeutics for obesity and rare genetic metabolic disorders. Aardvark Therapeutics was founded by Tien Lee in 2017. | $15M / Series A / Nov 29, 2019 | ||
| Lemon Healthcare is a one-stop mobile solution that offers smart medical services. Lemon Healthcare employs ICT-based technology to solve challenges in medical institutions, such as when patients make reservations, manage health data, and make payments. Furthermore, the company creates platforms such as mobile smart hospitals by connectinghospitals, pharmacies, and insurance companies. | $3.7M / Series A / Mar 18, 2018 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does BNH invest in?
BNH invests primarily in Health Care, Biotechnology and Medical startups, most often at Series A and Series B stage. Most of the 6 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did BNH last invest?
The most recent investment recorded for BNH closed in Nov 2022. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
